Akero Therapeutics Inc (NASDAQ:AKRO)

28.87
Delayed Data
As of Nov 25
 +0.56 / +1.98%
Today’s Change
10.78
Today|||52-Week Range
41.16
+30.07%
Year-to-Date
No recent news for Akero Therapeutics Inc.

Today’s Trading

Previous close28.31
Today’s open28.13
Day’s range28.13 - 29.38
Volume4,882
Average volume (3 months)185,901
Market cap$1.0B
Data as of 4:00pm ET, 11/25/2020

Growth & Valuation

Earnings growth (last year)+4.52%
Earnings growth (this year)+24.48%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.40

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA-0.14-0.62%
----
----
KRYSKrystal Biotech Inc-0.46-0.98%
Data as of 3:59pm ET, 11/25/2020

Financials

Next reporting dateMarch 22, 2021
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$0.00
Annual profit (last year)-$43.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts